Khalaf Khalil, Chamieh Marc, Welc Natalia, Singh Chandpreet, Kaouk Joanne Lynn, Kaouk Aiden, Mackiewicz Andrzej, Kaczmarek Mariusz, Perek Bartlomiej
Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.
Department of Cancer Immunology, Poznan University of Medical Sciences, Poznań, Poland.
Front Immunol. 2025 Jan 29;16:1461535. doi: 10.3389/fimmu.2025.1461535. eCollection 2025.
Atherosclerosis, previously regarded as a lipid storage disease, has now been classified as a chronic inflammatory disease. The hardening of arterial vessels characterizes atherosclerosis due to the accumulation of lipids in the arterial walls, eliciting an inflammatory response. The development of atherosclerosis occurs in various stages and is facilitated by many clinical factors, such as hypertension, hyperlipidemia, and inflammatory status. A large arsenal of cells has been implicated in its development. This review will summarize the phases of atherosclerotic formation and all the cells involved in either promoting or inhibiting its development.
动脉粥样硬化,以前被认为是一种脂质储存疾病,现在已被归类为慢性炎症性疾病。动脉血管硬化是动脉粥样硬化的特征,这是由于脂质在动脉壁中积累,引发炎症反应所致。动脉粥样硬化的发展发生在各个阶段,并受到许多临床因素的促进,如高血压、高脂血症和炎症状态。大量细胞参与了其发展过程。本综述将总结动脉粥样硬化形成的阶段以及所有促进或抑制其发展的细胞。